Replies to post #656 on CorMedix Inc (CRMD)

[Lazerking40]

I agree. July has been good. 2 patent applications approved both of which were published on July 5. DSMB now recommendation trial halt. Expenses now greatly reduced in Q3 & Q4 due to trial halt.

Now expect NDA application. If approved, which is likely, I expect Europe and Middle East sales to increase based on FDA approval. If we go direct to market in US, CRMD already has manufacturing and distribution channels in place.

Big question is how they plan to address capital concerns, but in my opinion, the great news opens up a lot more opportunities.

I expect to hear a lot between now and Q2 earnings call. Just my opinions....good luck to all.